Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model.
Ontology highlight
ABSTRACT: Despite its revolutionary success in hematological malignancies, chimeric antigen receptor T (CAR-T) cell therapy faces disappointing clinical results in solid tumors. The poor efficacy has been partially attributed to the lack of understanding in how CAR-T cells function in a solid tumor microenvironment. Hypoxia plays a critical role in cancer progression and immune editing, which potentially results in solid tumors escaping immunosurveillance and CAR-T cell-mediated cytotoxicity. Mechanistic studies of CAR-T cell biology in a physiological environment has been limited by the complexity of tumor-immune interactions in clinical and animal models, as well as by a lack of reliable in vitro models. A microdevice platform that recapitulates a 3D tumor section with a gradient of oxygen and int
SUBMITTER: Ando Y
PROVIDER: S-EPMC6448565 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA